MARÍA DOLORES
CABALLERO BARRIGÓN
Investigadora en el periodo 1998-2022
University of Texas Health Science Center at San Antonio
San Antonio, Estados UnidosPublicaciones en colaboración con investigadores/as de University of Texas Health Science Center at San Antonio (1)
2012
-
Results from a pivotal, open-label, phase II study of romidepsin in relapsed or refractory peripheral T-cell lymphoma after prior systemic therapy
Journal of Clinical Oncology, Vol. 30, Núm. 6, pp. 631-636